logo
‘Take Stance Against Hinduphobia': Indian Students Oppose Pakistani Event At Harvard After Pahalgam Attack

‘Take Stance Against Hinduphobia': Indian Students Oppose Pakistani Event At Harvard After Pahalgam Attack

News1828-04-2025
The students expressed grief over the attack and said that the terrorists carried out the assault deliberately on Hindu tourists by verifying their religion and then executed them.
Pahalgam terror attack: Indian students studying in US' Harvard University have urged the management to review the participation of Pakistani officials at the Pakistan Conference 2025 in the university in wake of the Pahalgam attack which claimed the lives of 26 people, mostly tourists and left several others injured.
In a letter addressed to the Harvard management, two Indian students, Surabhi Tomar and Abhishek Chaudhari, expressed grief over the terror attack and said that the terrorists carried out the assault deliberately on Hindu tourists by verifying their religion and then executed them.
'These acts of violence were not indiscriminate— they were calculated attacks based solely on religious identity," they said in the letter.
They further emphasised that Pakistan has also issued provocative threats of retaliation to New Delhi over subsequent restrictions imposed on Islamabad after the attack.
'While formally denying involvement, Pakistan's ministers and lawmakers have simultaneously issued aggressive warnings to India and reaffirmed their support for insurgent activity in Kashmir. Deputy Prime Minister and Finance Minister Ishaq Dar has even issued threats of retaliation, should India take any 'kinetic step" in response," the letter read.
The Indian students, pursuing Edward S. Mason Program in Public Policy and Management at Harvard Kennedy School, further expressed their opposition to the organisation of Pakistan Conference 2025 which is being scheduled to take place in the university. Pakistani delegates—including Minister of Finance Muhammad Aurangzeb and other high-ranking figures—are expected to participate in the upcoming event.
'Welcoming representatives of a government that not only denies accountability for but also ideologically supports such religion-based terrorism, risks Harvard being complicit in legitimizing those who enable or justify these crimes," the letter said.
The students then urged the Harvard management to issue a public statement condemning the attack; review the participation of Pakistani officials at the upcoming conference; and provide emotional and institutional support to affected students.
'We ask for the clarity, courage, and compassion for Hindu and Indian students grieving the targeted killing of members of their faith. We request you to take a stance against Hinduphobia," it read.
'We respectfully request that Harvard University: 1. Issue a public statement condemning the Pahalgam terror attacks and affirming support for victims of religion-based violence. 2. Review the participation of Pakistani officials at the Pakistan Conference 2025 in light of their government's ideological and rhetorical support for groups like LeT. 3. Provide emotional and institutional support to affected students through the Office for Equity, Diversity, Inclusion, and Belonging," the letter read.
'This is not about political posturing. It is about moral clarity. Harvard must ensure its campus
does not become a platform for whitewashing state-enabled religious terrorism, the letter concluded.
What Happened In Pahalgam?
In one of the biggest attacks in Jammu and Kashmir, Lashkar-linked terrorists opened fire on a group of tourists in Pahalgam on Tuesday, April 22, killing at least 26 people, including foreign tourists, and injuring many others. The Resistance Front (TRF), a Lashkar offshoot, claimed the responsibility for the attack.
Terrorists targeted a group of people, including women and elderly individuals, in the brazen attack afternoon.
After the attack, the diplomatic ties between India and Pakistan downgraded with New Delhi announcing several punitive measures, including suspension of Indus Water Treaty, cutting Islamabad Mission strength and expulsion of its military attaches.
First Published:
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US tariffs should not be cause for disengaging from trade talks, blocs
US tariffs should not be cause for disengaging from trade talks, blocs

Business Standard

time26 minutes ago

  • Business Standard

US tariffs should not be cause for disengaging from trade talks, blocs

The fundamental challenge for the Indian economy is to increase productivity and competitiveness premium Business Standard Editorial Comment Mumbai Listen to This Article The tariff rate of 25 per cent, which United States (US) President Donald Trump has decided will be applied to Indian exports to the US, may not, eventually, be the final rate. It may effectively wind up being higher if he carries out his threat to add a surcharge related to India's increasing purchases of Russian oil. It may be lower if New Delhi's negotiators pull some sort of a broader deal together. It is also worth remembering that there will be multiple exceptions to this headline tariff rate. Some goods that compose a large part of India-US trade —

Following are the top foreign stories at 2100 hours
Following are the top foreign stories at 2100 hours

News18

time36 minutes ago

  • News18

Following are the top foreign stories at 2100 hours

FGN6 BANGLA-HASINA ****Bangladesh tribunal commences trial of deposed PM Hasina over crimes against humanity Dhaka: Bangladesh's International Crimes Tribunal (ICT) on Sunday commenced the trial of deposed Prime Minister Sheikh Hasina in absentia over crimes against humanity related to the violent suppression of the 2024 student-led protests.**** FGN17 BANGLA-RALLIES ****B'desh: BNP's student wing, NCP hold rallies ahead of July Uprising anniversary Dhaka: Activists of the National Citizen Party and the BNP's student wing held separate rallies in Bangladesh on Sunday ahead of the first anniversary of the July Uprising that toppled the Sheikh Hasina-led government on August 5 last year.**** FGN9 PAK-IRAN-NUCLEAR ****Pakistan supports Iran's right to develop nuclear capability for peaceful purposes Islamabad: Pakistan on Sunday supported Iran's right to develop nuclear capability for peaceful purposes, as the two sides signed several agreements to expand cooperation in multiple fields.**** FGN8 PAK-IRAN-TRADE ****Pakistan: Iran decide to increase bilateral trade to USD 8 billion annually Islamabad: Pakistan and Iran agreed on Sunday to increase bilateral trade to USD 8 billion annually, taking advantage of their geography and the 'discount of distance," as trade ministers from the two countries held discussions to deepen economic and political ties.**** FGN14 US-INDIANS-ACCIDENT ****Four senior Indian-origin persons killed in car crash in West Virginia New York: In a tragic incident, four senior Indian-origin persons were killed in a car crash in West Virginia, authorities said on Sunday.

How Trump tariffs could impact Indian pharma's $8.7 bn dream run
How Trump tariffs could impact Indian pharma's $8.7 bn dream run

India Today

time42 minutes ago

  • India Today

How Trump tariffs could impact Indian pharma's $8.7 bn dream run

For long, the high-value US market has driven the growth of the storied Indian generic drugs industry, where companies like Cipla, Sun Pharma and Dr Reddy's Laboratories, among others, have successfully challenged hundreds of off-patent drugs in the US and established a soaring business FY24, India exported $8.7 billion (Rs 76,113 crore) worth of pharma products to the US, which comprises over 11 per cent of India's total merchandise exports to that the same period, India exported $77.5 billion (Rs 6.8 lakh crore) worth of merchandise goods to the US and imported $42.2 billion (Rs 3.7 lakh crore) worth of goods from it, resulting in a trade surplus of $35.3 billion (Rs 3 lakh crore) in India's US is India's largest destination for pharma exports, accounting for over 31 per cent of the country's total pharmaceutical exports. As much as 47 per cent of all generics consumed in the US are imported from India. However, the Donald Trump administration's threat of imposition of a 25 per cent reciprocal tariff from August 1 (up from 0 to 6.7 per cent at present) has thrown the Indian pharma industry in a bind. Shares of Indian pharma companies, led by Sun Pharma, fell close to 6 per cent on the NSE (National Stock Exchange) on August 1 following president Trump's statements on the tariff imposition, and his letters to 17 top US pharma companies asking them to reduce their rates in line with what prevailed in other countries. Some fear Trump may send a similar letter to Sun Pharma, which earns as much as 20 per cent of its total revenues from the US Indian industry was hoping against hope that Trump would not hike tariffs on generic drugs since these are life-saving. However, Trump had indicated earlier this year too that tariffs on pharma products would be 25 per cent from April 2 onwards, without pinpointing any nation. He later gave a 90-day reprieve to countries, and the new deadline for the tariffs was put as August imports roughly $800 million worth of pharmaceutical products from the US, and imposes a tariff of 10 per cent. Experts say that even if higher tariffs are imposed on active pharma ingredients (APIs), which are raw materials going into pharma production, India could still be competitive, if tariffs on other API-supplying countries are higher than that of the US will still be dependent on countries like India since the cost of manufacturing certain drugs in the US would be at least six times compared to that of manufacturing the same product in India, say industry US market, which relies heavily on India for APIs and low-cost generics, would struggle to find alternatives, according to Namit Joshi, chairman of Pharmexcil (Pharmaceuticals Export Promotion Council of India). 'Efforts to shift pharmaceutical manufacturing and API production to other countries or within the US will take at least 3-5 years to establish meaningful capacity,' he was quoted in media reports. advertisement'There is no need for panic. The industry should lie low for now since the US has not yet increased the tariffs. Who else can give the US such competitively-priced goods in large quantities and high quality?' Daara Patel, secretary general of the Indian Drug Manufacturers Association, had said in an interview to INDIA TODAY in April. 'Even if it increases up to 10 per cent, the industry should be able to absorb it or pass it on to the US consumers. They would not mind paying for it since it all works on insurance money,' he what if the US decides to go for a higher tariff? 'In case the US raises tariffs beyond 15 per cent, India will have to look at newer markets in East Africa and the Middle East. These markets are neither high value nor high in volumes, but it will be a better option than dealing with an uncertain US market alone,' Patel had saidSubscribe to India Today Magazine- EndsTune InMust Watch

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store